当前抗逆转录病毒疗法对神经艾滋病的影响。 - Suppr

Suppr

超能文献

Impact of current antiretroviral therapies on neuroAIDS.

作者信息

Vivithanaporn Pornpun, Gill M John, Power Christopher

出版信息

Expert Rev Anti Infect Ther. 2011 Apr;9(4):371-4. doi: 10.1586/eri.10.179.

DOI:10.1586/eri.10.179

PMID:21504390

Abstract

摘要

相似文献

Impact of current antiretroviral therapies on neuroAIDS.

Expert Rev Anti Infect Ther. 2011 Apr;9(4):371-4. doi: 10.1586/eri.10.179.

NeuroAIDS in sub-Saharan Africa: a clinical review.

Ann Afr Med. 2013 Jan-Mar;12(1):1-10. doi: 10.4103/1596-3519.108242.

[HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].

No To Shinkei. 2004 Apr;56(4):301-10.

Cell death mechanisms in HIV-associated dementia: the involvement of syncytia.

Cell Death Differ. 2005 Aug;12 Suppl 1:855-8. doi: 10.1038/sj.cdd.4401590.

HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).

Microbes Infect. 2011 May;13(5):419-25. doi: 10.1016/j.micinf.2011.01.004. Epub 2011 Jan 22.

Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?

J Clin Virol. 2010 Dec;49(4):231-8. doi: 10.1016/j.jcv.2010.08.001. Epub 2010 Sep 15.

Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.

Can J Neurol Sci. 2002 Feb;29(1):19-32. doi: 10.1017/s0317167100001682.

Treatment of opportunistic infections and lymphoma in the nervous system.

J HIV Ther. 2002 Feb;7(1):21-5.

Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.

J Antimicrob Chemother. 2010 Jun;65(6):1100-7. doi: 10.1093/jac/dkq096. Epub 2010 Mar 25.

HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.

AIDS. 2003 Apr;17 Suppl 1:S51-64.

引用本文的文献

Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies.

Pharmacol Rep. 2023 Oct;75(5):1138-1151. doi: 10.1007/s43440-023-00515-y. Epub 2023 Aug 21.

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Mol Biomed. 2020;1(1):15. doi: 10.1186/s43556-020-00019-8. Epub 2020 Dec 10.

Treating viruses in the brain: Perspectives from NeuroAIDS.

Neurosci Lett. 2021 Mar 23;748:135691. doi: 10.1016/j.neulet.2021.135691. Epub 2021 Jan 30.

HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

J Neurovirol. 2019 Aug;25(4):560-577. doi: 10.1007/s13365-019-00757-8. Epub 2019 May 17.

Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function .

Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01307-17. Print 2017 Dec.

HIV and viral protein effects on the blood brain barrier.

Tissue Barriers. 2016 Jan 28;4(1):e1143543. doi: 10.1080/21688370.2016.1143543. eCollection 2016 Jan-Mar.

Towards nanomedicines for neuroAIDS.

Rev Med Virol. 2014 Mar;24(2):103-24. doi: 10.1002/rmv.1778. Epub 2014 Jan 7.

Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes.

Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1453-64. doi: 10.1517/17425255.2013.816285. Epub 2013 Jul 4.

Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes.

Expert Opin Drug Metab Toxicol. 2012 Nov;8(11):1363-75. doi: 10.1517/17425255.2012.714366. Epub 2012 Aug 8.

Viral quasispecies evolution.

Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216. doi: 10.1128/MMBR.05023-11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验